INSIGHTS ON UPSTREAM MANUFACTURING
-
![From Gene Editing To NGS-Based T Cell Characterization]( "From Gene Editing To NGS-Based T Cell Characterization")
From Gene Editing To NGS-Based T Cell CharacterizationGene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.
-
![lonza clones]( "Faster Clones, Simpler Process: What's Changing In CHO Expression?")
Faster Clones, Simpler Process: What's Changing In CHO Expression?This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.
-
![GettyImages-2217581928 manufacturing, production]( "End-To-End Process Scalability Of HEK 293 Media For High Titer AAV Production")
End-To-End Process Scalability Of HEK 293 Media For High Titer AAV ProductionExplore how controlled bioreactor environments enable optimization of critical process parameters and support robust, scalable AAV production from development through manufacturing.
-
![Advancing Next Gen Antibodies And ADCs: From AI Driven Cell Line Development To Integrated Manufacturing Bucket]( "Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing")
Advancing Next Gen Antibodies: From AI Driven CLD To ManufacturingSee how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.
-
Asahi Kasei Bioprocess - Made In The USA5/29/2026
Discover how combining Japanese precision with American ingenuity creates reliable bioprocess filtration solutions built for consistent, batch-after-batch manufacturing performance.
-
Microbial Expertise That Scales Globally5/28/2026
Want consistency and control in microbial manufacturing? We combine decades of expertise, advanced automation, and global processes to deliver reliable, scalable fermentation performance.
-
Scaling Success With Perfusion Manufacturing5/28/2026
Interested in improving cell viability in biologics manufacturing? See how perfusion processes help maintain healthier cell cultures by continuously removing waste products.
-
How Integrated Molecule Innovation Is Transforming Vet Therapeutics5/27/2026
Cell line development underpins modern animal health innovation, enabling production of targeted biologics and supporting integrated approaches that improve therapeutic precision, scalability, and treatment outcomes.
UPSTREAM MANUFACTURING SOLUTIONS
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "GPEx® Lightning: Stable Cell Line Development For Complex Biologics")
GPEx® Lightning delivers stable cell pools in 25 days, titers exceeding 15g/L for mAbs and 11g/L for bispecifics, and 60+ generations of stability — compressing timelines by 6–12 weeks.
-
![GettyImages-1002000796-lab-research-scientist-development]( "Madison: Clinical, Commercial Drug Substance Development")
Catalent Madison offers gene-to-GMP drug substance in 8 months via GPEx Lightning CHO cell lines, hitting 15+ g/L, backed by 24 approved products and 5 GMP trains up to 4,000 L.
-
![GettyImages-1165637777 DNA]( "CHO Residual DNA Quantitation")
Highly sensitive detection of trace DNA impurities supports safer manufacturing. Combining rapid workflows, strong specificity, and reliable recovery from complex samples enables confident monitoring.
-
![resDNASEQ Host Cell Residual]( "Leading The Way In Rapid Quantitation Of Host Cell DNA")
Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.
-
![Hyclone]( "Increase Cell Culture Yield Without Increasing Aggregation")
Designed for CHO cell culture processes, the HyClone™ glycan supplement enhances galactosylation and maintains stable culture performance.
